慢性活动性肝炎(CAH)的治疗仍是一个相当棘手的临床问题,目前尚缺乏具有肯定疗效的治疗药物。近年来,有几种治疗CAH的新方法正在进行临床评价,现扼要介绍于下: 一、干扰素干扰素是在干扰素诱生剂作用下,由细胞合成的一种糖蛋白,它在转录水平抑制病毒复制。虽然细胞在病毒感染前接触干扰素,可获得最充分的保护,但是慢性病持续存在意味着病毒继续不断地感染着正常细胞。与其他病毒感染不同,急性或慢 The treatment of chronic active hepatitis (CAH) remains a rather intractable clinical problem and there is currently no cure for this affliction. In recent years, there are several new methods for the treatment of CAH clinical evaluation, is now briefly described in the following: First, the interferon Interferon is an interferon inducer, the synthesis of a glycoprotein, which is transcribed Inhibit viral replication horizontally. Although cells are most adequately protected from exposure to interferon prior to viral infection, the persistence of chronic disease means that the virus continues to infect normal cells. Unlike other viral infections, acute or slow